I/VC  WRF Capital

http://www.wrfseattle.org





     Office Locations:

2815 Eastlake Avenue E, Suite 300
Seattle, WA 98102
Phone: 206-336-5600
Fax: 206-336-5615

 

Stages:

  • Seed


 

Industries:

  • Energy & Clean Tech
  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Retail & Restaurant
  • Software & Internet

  •  

    Description:

    Washington Research Foundation (WRF) was founded in 1981 to help Washington State research institutions capture value from emerging technologies through intellectual property management and start-up investment activities. WRF is an independent private foundation whose operational revenue comes from retained funds from licensing and investing activities. WRF Capital manages Washington Research Foundation's (WRF) seed venture fund by creating and investing primarily in technology-based start-up companies that have strong ties to the University of Washington and other non-profit research institutions in Washington State. WRF Capital invests in two types of companies: (1) WRF founded companies in which WRF Capital and an entrepreneur create a business concept and start a company and (2) Non-WRF founded companies in which WRF Capital invests in a company opportunity presented by an entrepreneur. In both cases, WRF Capital actively seeks co-investors, investing up to $2 million in the firm's portfolio companies with proceeds from investments used to make financial gifts to Washington State research institutions. WRF invests only in companies located in Washington State with ties to not-for-profit research insitutions. The industry focus includes IT, Life Sciences, and Physical Sciences. In addition to providing seed capital through WRF Capital, the WRF leases office space to technology-based start-ups through the WRF Venture Center. The WRF Venture Center offers entrepreneurs short-term, flexible office facilities and business support in a desirable location on Lake Union, midway between the University District and downtown Seattle. WRF has funded 114 local startups through WRF Capital, a reserve pool of funds for investing in early-stage Washington state companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Loretta Little Managing Director
    Susan Coliton Interim President & CEO

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/20/2024


      Talus Bioscience


      WA


      $11,200,000


      Seed+


      02/01/2024


      Proniras


      WA


      $4,650,000


      Series B


     

    Portfolio companies include:


      AbSci
        web link


      AdaptX
        web link


      Alder BioPharmaceuticals
        web link


      AnswerDash
        web link


      ApoGen Biotechnologies
        web link


      Arzeda
        web link


      FlexMinder
        web link


      KayoThera
        web link


      Proniras
        web link


      Qazzow
        web link


      Resolve Therapeutics
        web link


      Somalytics
        web link


      Talus Bioscience
        web link


      ThruWave
        web link


      Uptake
        web link


      Wavely Diagnostics
        web link


      WiBotic
        web link


     

    Recent News: